EVs isolated from various cancer cell lines also downregulate natural-killer group 2, member D (NKG2D) expression in NK cells and CD8+ cytotoxic MOLT4 cells44, where NKG2D is known to function as an activating receptor on the cell surface. The gene discussed is CD8A; the disease is cancer.